{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:30:17Z","timestamp":1780471817862,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Inf."],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is a slowly progressing disease for which there is no known therapeutic cure at present. Ongoing research around the world is actively engaged in the quest for identifying markers that can help predict the future cognitive state of individuals so that measures can be taken to prevent the onset or arrest the progression of the disease. Researchers are interested in both biological and neuropsychological markers that can serve as good predictors of the future cognitive state of individuals. The goal of this study is to identify non-invasive, inexpensive markers and develop neural network models that learn the relationship between those markers and the future cognitive state. To that end, we use the renowned Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) data for a handful of neuropsychological tests to train Recurrent Neural Network (RNN) models to predict future neuropsychological test results and Multi-Level Perceptron (MLP) models to diagnose the future cognitive states of trial participants based on those predicted results. The results demonstrate that the predicted cognitive states match the actual cognitive states of ADNI test subjects with a high level of accuracy. Therefore, this novel two-step technique can serve as an effective tool for the prediction of Alzheimer\u2019s disease progression. The reliance of the results on inexpensive, non-invasive tests implies that this technique can be used in countries around the world including those with limited financial resources.<\/jats:p>","DOI":"10.1186\/s40708-022-00169-1","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T11:02:45Z","timestamp":1664276565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Early detection of Alzheimer\u2019s disease using neuropsychological tests: a predict\u2013diagnose approach using neural networks"],"prefix":"10.1186","volume":"9","author":[{"given":"Devarshi","family":"Mukherji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manibrata","family":"Mukherji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Mukherji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"169_CR1","doi-asserted-by":"crossref","unstructured":"Report (2018) 2018 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 14(3):367\u2013429","DOI":"10.1016\/j.jalz.2018.02.001"},{"issue":"3","key":"169_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","volume":"3","author":"R Brookmeyer","year":"2007","unstructured":"Brookmeyer R, Johnson E, Ziegler-Graham K, Michael Arrighi H (2007) Forecasting the global burden of Alzheimer\u2019s disease. Alzheimer\u2019s Dement 3(3):186\u2013191","journal-title":"Alzheimer\u2019s Dement"},{"issue":"4","key":"169_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/alzrt269","volume":"6","author":"JL Cummings","year":"2014","unstructured":"Cummings JL, Morstorf T, Zhong K (2014) Alzheimer\u2019s disease drug development pipeline: few candidates, frequent failures. Alzheimer\u2019s Res Ther 6(4):37","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"5","key":"169_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10072-016-2477-1","volume":"37","author":"V Berti","year":"2016","unstructured":"Berti V, Polito C, Lombardi G, Ferrari C, Sorbi S, Pupi A (2016) Rethinking on the concept of biomarkers in preclinical Alzheimer\u2019s disease. Neurol Sci 37(5):663\u2013672","journal-title":"Neurol Sci"},{"issue":"3","key":"169_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","volume":"12","author":"B Dubois","year":"2016","unstructured":"Dubois B, Hampel H et al (2016) Preclinical Alzheimer\u2019s disease: definition, natural history, and diagnostic criteria. Alzheimer\u2019s Dement 12(3):292\u2013323","journal-title":"Alzheimer\u2019s Dement"},{"issue":"4","key":"169_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Lance MS, Martins R, Maruff P, Ames D, Rowe CC, Masters CL (2013) Amyloid deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol 12(4):357\u2013367","journal-title":"Lancet Neurol"},{"issue":"1","key":"169_CR7","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1038\/s41598-018-37149-7","volume":"9","author":"B Goudey","year":"2019","unstructured":"Goudey B, Fung BJ, Schieber C, Faux NG (2019) A blood-based signature of cerebrospinal fluid A1\u201342 status. Sci Rep 9(1):4163","journal-title":"Sci Rep"},{"issue":"1","key":"169_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WAD.0000000000000144","volume":"30","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Suhy J, Chiao P, Chen T, Klein G, Purcell D, Oh J, Verma A, Sampat M, Barakos J (2016) Amyloid PET screening for enrichment of early-stage alzheimer disease clinical trials: experience in a phase 1b clinical trial. Alzheimer Dis Assoc Disord 30(1):1\u20137","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"169_CR9","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3233\/JAD-170531","volume":"62","author":"L Shi","year":"2018","unstructured":"Shi L, Baird AL, Westwood S, Hye A, Dobson R, Thambisetty M, Lovestone S (2018) A decade of blood biomarkers for Alzheimer\u2019s disease research: an evolving field, improving study designs, and the challenge of replication. J Alzheimer\u2019s Dis 62(3):1181\u20131198","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"169_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.trci.2017.05.002","volume":"3","author":"J Cummings","year":"2017","unstructured":"Cummings J, Lee G, Mortsdorf T, Ritter A, Zhong K (2017) Alzheimer\u2019s disease drug development pipeline: 2017. Alzheimer\u2019s Dement Transl Res Clin Interv 3(3):367\u2013384","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"},{"issue":"5","key":"169_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1017\/S1355617701755105","volume":"7","author":"MS Albert","year":"2001","unstructured":"Albert MS, Moss MB, Tanzi R, Jones K (2001) Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc 7(5):631\u2013639","journal-title":"J Int Neuropsychol Soc"},{"key":"169_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/1850909","volume":"2017","author":"P Battista","year":"2017","unstructured":"Battista P, Salvatore C, Castiglioni I (2017) Optimizing neuropsychological assessments for cognitive, behavioral, and functional impairment classification: a machine learning study. Behav Neurol 2017:1\u201319","journal-title":"Behav Neurol"},{"issue":"1","key":"169_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11065-008-9054-1","volume":"18","author":"MW Bondi","year":"2008","unstructured":"Bondi MW, Jak AJ, Delano-Wood L, Jacobson MW, Delis DC, Salmon DP (2008) Neuropsychological contributions to the early identification of Alzheimer\u2019s disease. Neuropsychol Rev 18(1):73\u201390","journal-title":"Neuropsychol Rev"},{"issue":"3","key":"169_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/JAD-130881","volume":"38","author":"G Gainotti","year":"2014","unstructured":"Gainotti G, Quaranta D, Vita MG (2014) Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer\u2019s disease\u2019. J Alzheimer\u2019s Dis 38(3):481\u2013495","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"11","key":"169_CR15","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1212\/01.WNL.0000163773.21794.0B","volume":"64","author":"MC Tierney","year":"2005","unstructured":"Tierney MC, Yao C, Kiss A, McDowell I (2005) Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 64(11):1853\u20131859","journal-title":"Neurology"},{"issue":"9","key":"169_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/13803395.2015.1067290","volume":"37","author":"A Weakley","year":"2015","unstructured":"Weakley A, Williams JA, Schmitter-Edgecombe M, Cook DJ (2015) Neuropsychological test selection for cognitive impairment classification: a machine learning approach. J Clin Exp Neuropsychol 37(9):899\u2013916","journal-title":"J Clin Exp Neuropsychol"},{"issue":"3","key":"169_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1590\/S1980-57642009DN30300007","volume":"3","author":"EML Pimentel","year":"2009","unstructured":"Pimentel EML (2009) Role of neuropsychological assessment in the differential diagnosis of Alzheimer\u2019s disease and vascular dementia. Dement Neuropsychol 3(3):214\u2013221","journal-title":"Dement Neuropsychol"},{"issue":"1","key":"169_CR18","doi-asserted-by":"publisher","first-page":"9161","DOI":"10.1038\/s41598-018-27337-w","volume":"8","author":"T Wang","year":"2018","unstructured":"Wang T, Qiu RG, Ming Y (2018) Predictive modeling of the progression of Alzheimer\u2019s disease with recurrent neural networks. Sci Rep 8(1):9161","journal-title":"Sci Rep"},{"key":"169_CR19","unstructured":"Tabert MH, Manly JJ, Liu X, Pelton G, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell KL, Stern Y, Devanand DP (2017) Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. JAMA Psychiatry (Chicago, Ill.)"},{"key":"169_CR20","doi-asserted-by":"publisher","first-page":"769982","DOI":"10.3389\/fncom.2021.769982","volume":"15","author":"HH Seyed","year":"2022","unstructured":"Seyed HH, Babajani-Feremi A, The Alzheimer\u2019s Disease Neuroimaging Initiative (2022) Prediction and modeling of neuropsychological scores in Alzheimer\u2019s disease using multimodal neuroimaging data and artificial neural networks. Front Comput Neurosci 15:769982","journal-title":"Front Comput Neurosci"},{"key":"169_CR21","first-page":"116317","volume":"206","author":"S Tabarestani","year":"2020","unstructured":"Tabarestani S, Aghili M, Eslami M, Cabrerizo M, Barreto A, Rishe N, Curiel RE, Loewenstein D, Duara R, Adjouadi M (2020) A distributed multitask multimodal approach for the prediction of Alzheimer\u2019s disease in a longitudinal study. NeuroImage (Orlando, Fla) 206:116317","journal-title":"NeuroImage (Orlando, Fla)"},{"issue":"7","key":"169_CR22","first-page":"3381","volume":"50","author":"M Liu","year":"2020","unstructured":"Liu M, Zhang J, Lian C, Shen D (2020) Weakly supervised deep learning for brain disease prognosis using MRI and incomplete clinical scores. IEEE Trans Cybern 50(7):3381\u20133392","journal-title":"IEEE Trans Cybern"},{"key":"169_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fninf.2018.00035","volume":"12","author":"M Liu","year":"2018","unstructured":"Liu M, Cheng D, Yan W (2018) Classification of Alzheimer\u2019s disease by combination of convolutional and recurrent neural networks using FDG-PET images. Front Neuroinform 12:35","journal-title":"Front Neuroinform"},{"key":"169_CR24","doi-asserted-by":"publisher","first-page":"584641","DOI":"10.3389\/fnins.2021.584641","volume":"15","author":"T-H Kung","year":"2021","unstructured":"Kung T-H, Chao T-C, Xie Y-R, Pai M-C, Kuo Y-M, Lee GGC (2021) Neuroimage biomarker identification of the conversion of mild cognitive impairment to Alzheimer\u2019s disease. Front Neurosci 15:584641","journal-title":"Front Neurosci"},{"key":"169_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3389\/fneur.2019.00904","volume":"10","author":"HH Seyed","year":"2019","unstructured":"Seyed HH, Ebrahimzadeh A, Babajani-Feremi A (2019) Identification of the early stage of Alzheimer\u2019s disease using structural MRI and resting-state fMRI. Front Neurol 10:904","journal-title":"Front Neurol"},{"key":"169_CR26","first-page":"511","volume":"65","author":"SF Eskildsen","year":"2013","unstructured":"Eskildsen SF, Coupe P, Garc\u0131a-Lorenzo D, Fonov V, Pruessner JC, Louis CD (2013) Prediction of Alzheimer\u2019s disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning. NeuroImage (Orlando, Fla) 65:511\u2013521","journal-title":"NeuroImage (Orlando, Fla)"},{"issue":"4","key":"169_CR27","first-page":"1832","volume":"39","author":"L Ferrarini","year":"2008","unstructured":"Ferrarini L, Palm WM, Olofsen H, van der Landen R, Blauw GJ, Westendorp RGJ, Bollen LEM, Middelkoop HAM, Reiber JHC, van Buchem MA, Admiraal Behloul F (2008) MMSE scores correlate with local ventricular enlargement in the spectrum from cognitively normal to Alzheimer disease. NeuroImage (Orlando, Fla) 39(4):1832\u20131838","journal-title":"NeuroImage (Orlando, Fla)"},{"issue":"2","key":"169_CR28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1148\/radiol.2018180958","volume":"290","author":"Y Ding","year":"2019","unstructured":"Ding Y, Sohn JH, Kawczynski MG, Trivedi H, Harnish R, Jenkins NW, Lituiev D, Copeland TP, Aboian MS, Aparici CM, Behr SC, Flavell RR, Huang S-Y, Zalocusky KA, Nardo L, Seo Y, Hawkins RA, Pampaloni MH, Hadley D, Franc BL (2019) A deep learning model to predict a diagnosis of Alzheimer disease by using 18F-FDG PET of the brain. Radiology 290(2):456\u2013464","journal-title":"Radiology"},{"issue":"4","key":"169_CR29","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","volume":"6","author":"PK Crane","year":"2012","unstructured":"Crane PK, Carle A, Gibbons LE, Insel P, Scott Mackin R, Gross A, Jones RN, Mukherjee S, McKay Curtis S, Harvey D, Weiner M, Mungas D (2012) Development and assessment of a composite score for memory in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav 6(4):502\u2013516","journal-title":"Brain Imaging Behav"},{"issue":"1","key":"169_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.trci.2019.07.001","volume":"5","author":"J Albright","year":"2019","unstructured":"Albright J (2019) Forecasting the progression of Alzheimer\u2019s disease using neural networks and a novel preprocessing algorithm. Alzheimer\u2019s Dement Transl Res Clin Interv 5(1):483\u2013491","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"},{"key":"169_CR31","doi-asserted-by":"crossref","unstructured":"Chen T, Shang C, Su P, et al (2021) Assessing significance of cognitive assessments for diagnosing alzheimer\u2019s disease with fuzzy-rough feature selection. In: Advances in computational intelligence systems, Cham, Springer International Publishing, pp 450\u2013462","DOI":"10.1007\/978-3-030-87094-2_40"},{"key":"169_CR32","doi-asserted-by":"crossref","unstructured":"Mugruza-Vassallo CA (2016) Database methodology for therapy evaluation in auditory schizophrenia disorder based on continuity evolution of symptoms. In: IEEE Oct 2016, pp 298\u2013303","DOI":"10.1109\/INFOCOMAN.2016.7784261"},{"key":"169_CR33","unstructured":"Choi E, Bahadori MT, Schuetz A, Stewart WF, Sun J (2016) Doctor AI: predicting clinical events via recurrent neural networks. In: JMLR workshop and conference proceedings, Aug 2016, 56, pp 301\u2013318"},{"key":"169_CR34","doi-asserted-by":"crossref","unstructured":"Esteban C, Staeck O, Yang Y, Tresp V (2016) Predicting clinical events by combining static and dynamic information using recurrent neural networks","DOI":"10.1109\/ICHI.2016.16"},{"key":"169_CR35","unstructured":"Lipton ZC, Kale DC, Elkan C, Wetzel R (2015) Learning to diagnose with LSTM recurrent neural networks"},{"key":"169_CR36","unstructured":"Lipton ZC, Berkowitz J, Elkan C (2015) A critical review of recurrent neural networks for sequence learning"},{"key":"169_CR37","unstructured":"Mostafa MG, S\u00f8rensen L, Ourselin S, Nielsen M (2021) CARRNN: a continuous autoregressive recurrent neural network for deep representation learning from sporadic temporal data"},{"issue":"7","key":"169_CR38","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34(7):939","journal-title":"Neurology"},{"issue":"1","key":"169_CR39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.trci.2019.06.004","volume":"5","author":"T Yagi","year":"2019","unstructured":"Yagi T, Kanekiyo M, Ito J, Ihara R, Suzuki K, Iwata A, Iwatsubo T, Aoshima K (2019) Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer\u2019s disease in the Japanese Alzheimer\u2019s Disease Neuroimaging Initiative study. Alzheimer\u2019s Dement Transl Res Clin Interv 5(1):364\u2013373","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"}],"container-title":["Brain Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40708-022-00169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40708-022-00169-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40708-022-00169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T11:04:09Z","timestamp":1664276649000},"score":1,"resource":{"primary":{"URL":"https:\/\/braininformatics.springeropen.com\/articles\/10.1186\/s40708-022-00169-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["169"],"URL":"https:\/\/doi.org\/10.1186\/s40708-022-00169-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.17.21249822","asserted-by":"object"}]},"ISSN":["2198-4018","2198-4026"],"issn-type":[{"value":"2198-4018","type":"print"},{"value":"2198-4026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ADNI provided access to all data used in this study and the authors used their guidelines for acknowledging them in the author section. The manuscript received approval from ADNI for submission of the research for publication. All authors of the study have provided consent for submitting this research for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the final copy of the manuscript and have provided consent for its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}